Results 31 to 40 of about 1,155,096 (237)

Higher Risk for Sjögren’s Syndrome in Patients With Fibromyalgia: A Nationwide Population-Based Cohort Study

Frontiers in Immunology, 2021
ObjectivesClinically, associations have been observed between Sjögren’s syndrome and fibromyalgia. Nonetheless, population-based evidence evaluating the risk of Sjögren’s syndrome in fibromyalgia patients is lacking.
Shuo-Yan Gau, Pui-Ying Leong, Pui-Ying Leong, Cheng-Li Lin, Cheng-Li Lin, Hsi-Kai Tsou, Hsi-Kai Tsou, Hsi-Kai Tsou, James Cheng-Chung Wei, James Cheng-Chung Wei, James Cheng-Chung Wei   +10 more
doaj   +1 more source

DIAGNOSIS OF THE SYNDROME OF SCHEGREN. REVIEW

Медична наука України, 2018
Relevance. Sjogren's syndrome is included in the group of diffuse connective tissue diseases and ranks third among them. Sjögren's syndrome remains unidentified in half the cases of the disease with clinical manifestations.
D.V. Topchy
doaj   +1 more source

Gls1 in Sjogren's syndrome

, 2022
The original analyzed data of the investigation of Gls1 in Sjogren's ...
Chuangqi Yu (3484583), Lingyan Zheng (3484595), Jiayao Fu (11516644), Yiping Pu (3484586)   +3 more
core   +1 more source

An Unusual Initial Presentation of Sjögren’s Syndrome: Severe Hypokalemic Paralysis Secondary to Distal Renal Tubular Acidosis

Eurasian Journal of Medicine, 2019
Sjögren’s syndrome is mainly affects the exocrine glands. Patients usually complain of persistent dryness of the mouth and eyes. However, nonexocrine organs such as the kidneys are often affected in these patients.
Erkan Sengul, Fatih Bunul, Ayten Yazici, Aysun Sengul, Sevim Dindar, Gökçen Selma Kilic Halhalli, Emine Binnetoglu   +6 more
doaj   +1 more source

Primary Sjogren’s Syndrome with Bicytopenia: A Case Report

Journal of Nepal Medical Association
Sjogren’s syndrome is a chronic multisystem autoimmune disease presenting a wide variety of clinical manifestations ranging from mild sicca symptoms to severe systemic symptoms involving pulmonary, renal, musculoskeletal, cutaneous, and haematological ...
Deepankar Raj Pathak, Ashish Kumar Chaurasiya, Rasish Subedi, Prabin Khatri, Pooja Shah   +4 more
doaj   +1 more source

Fibrous histiocytoma as first presentation in systemic lupus erythematosus and sero-positive Sjögren's syndrome

American Journal of Ophthalmology Case Reports, 2018
Purpose: To describe a triad of fibrous histiocytoma, Systemic Lupus Erythematosus and Sero-positive Sjögren's Syndrome. Observations: This case was diagnosed first as bilateral fibrous histiocytoma of cheeks, which on further investigations proved to be
Abdullah Al-Mujaini, Kashinatha Shenoy, Upender Wali   +2 more
doaj   +1 more source

Bowen’s disease in a patient with Primary Sjögren’s syndrome: A case report and a review of the literature

Journal of Dermatology and Dermatologic Surgery, 2015
A rare case of Bowen’s disease (BD) in a patient with Primary Sjögren’s syndrome is reported. A 42-year-old woman suffering from Primary Sjögren’s syndrome retained on the basis of clinical and serological findings, was admitted 3 years later for genital
Besma Ben Dhaou, Imen Rachdi, Rym Ben Mously, Zohra Aydi, Fatma Daoud, Lilia Baili, Insaf Mokhtar, Fatma Boussema   +7 more
doaj   +1 more source

Sjögren’s syndrome with rapidly progressive motor neuron disease: a case report

Journal of International Medical Research, 2020
Sjögren’s syndrome is an autoimmune disease that can affect multiple systems. Sjögren’s syndrome with motor neuron disease is rarely reported. Herein, we describe a patient with rapidly progressive motor neuron disease secondary to Sjögren’s syndrome.
Huijia Yang, Xiaozhong Jing, Jinhua Yan, Dihui Ma   +3 more
doaj   +1 more source

Recent Advances on Primary Sjogren's Syndrome and Depression Relationship [PDF]

, 2023
Primary Sjogren's syndrome is a chronic autoimmune disorder that affects the exocrine glands, leading to dryness of the eyes, mouth, and other mucous membranes.
Sun lei, Yang gaoyuan
core   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini, Giulia Tammam, Andra Ezaru, Manuela Gambella, Benoît Sanson, Luisa Villa, Michele Cavalli, Mihai‐Bogdan Ioncea, Angela Puma, Sabrina Sacconi   +9 more
wiley   +1 more source